Target intelligence / Profile preview

Neuronal membrane lipid raft (NMLR)

Target
NMLR
Molecular classification
Membrane microdomain, Lipid-protein assembly
01

Overview

Neuronal membrane lipid rafts are specialized, highly ordered microdomains within the neuronal plasma membrane, characterized by an enrichment of cholesterol, sphingolipids, and scaffolding proteins such as flotillins (Pike, 2006, J Lipid Res). These domains function as dynamic signaling hubs that compartmentalize and organize various proteins, including neurotransmitter receptors, ion channels, and G-protein coupled receptors, thereby regulating synaptic transmission and plasticity (Sebastião et al., 2013, Front Physiol). In neurodegenerative diseases like Alzheimer's, lipid rafts serve as the primary site for the amyloidogenic processing of amyloid precursor protein (APP) by beta- and gamma-secretases, leading to the accumulation of amyloid-beta plaques (Ehehalt et al., 2003, J Cell Biol). Consequently, these microdomains are considered therapeutic targets for drugs that aim to alter membrane composition, such as statins or polyunsaturated fatty acids, to disrupt the assembly of toxic protein aggregates or modulate aberrant signaling (Simons & Gerl, 2010, Nat Rev Mol Cell Biol). However, because lipid rafts are ubiquitous across various tissues, achieving brain-specific modulation remains a significant pharmacological challenge.

Other names
Lipid raftsMembrane microdomainsDetergent-resistant membranesCholesterol-rich microdomainsSynaptic lipid rafts
02

Mechanism of action

Cholesterol depletion and structural disruption of membrane microdomains to modulate protein-protein interactions and signaling cascades.

03

Biological functions

Signal transductionSynaptic plasticityNeurotransmitter receptor traffickingAxonal growthEndocytosis
04

Disease associations

Alzheimer's diseaseParkinson's diseaseHuntington's diseasePrion diseasesAmyotrophic lateral sclerosis
05

Safety considerations

Non-specific disruption of cellular membranesPotential impairment of essential synaptic signalingSystemic metabolic effectsNeurotoxicity from excessive cholesterol depletion
06

Interacting drugs

Simvastatin

5 more in the full profile.

07

Biomarkers

Flotillin-1Caveolin-1GM1 gangliosideCholesterolSphingomyelin

Beyond the preview

Go deeper on Neuronal membrane lipid raft (NMLR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal membrane lipid raft (NMLR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call